New hope for lung cancer patients: drug after standard therapy may delay progression
NCT ID NCT07161388
First seen Nov 01, 2025 · Last updated May 26, 2026 · Updated 24 times
Summary
This study looks at whether the drug durvalumab, given after chemoradiation, can help control limited-stage small-cell lung cancer. About 200 adults in China will receive durvalumab and be followed to see how long their cancer stays under control. The goal is to understand how well this treatment works in everyday medical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIMITED-STAGE SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGBeijing, China
-
Research Site
RECRUITINGCangzhou, China
-
Research Site
RECRUITINGDongguan, China
-
Research Site
RECRUITINGFuzhou, China
-
Research Site
RECRUITINGGuangzhou, China
-
Research Site
RECRUITINGHuzhou, China
-
Research Site
RECRUITINGJinan, 250117, China
-
Research Site
RECRUITINGJinan, China
-
Research Site
RECRUITINGNanjing, China
-
Research Site
RECRUITINGNanning, China
-
Research Site
RECRUITINGNingbo, China
-
Research Site
RECRUITINGShanghai, China
-
Research Site
RECRUITINGShenyang, China
-
Research Site
RECRUITINGShijiazhuang, China
-
Research Site
RECRUITINGTaiyuan, China
-
Research Site
RECRUITINGTianjing, China
-
Research Site
TERMINATEDTianjing, China
-
Research Site
RECRUITINGWuhan, China
-
Research Site
RECRUITINGWuxi, China
-
Research Site
RECRUITINGYangzhou, China
-
Research Site
RECRUITINGZhengzhou, China
Conditions
Explore the condition pages connected to this study.